Swedish Healthtech Stock News

The European market has recently faced mixed performance, with the pan-European STOXX Europe 600 Index ending slightly lower amid resilient economic data and geopolitical uncertainties. In this environment, small-cap stocks can offer unique opportunities for investors seeking growth potential, particularly when there is evidence of insider buying as a sign of confidence in a company's future prospects.

Those following along with Fabege AB (publ) ( STO:FABG ) will no doubt be intrigued by the recent purchase of shares by...

It's been a good week for BTS Group AB (publ) ( STO:BTS B ) shareholders, because the company has just released its...

Investors who take an interest in Mangold Fondkommission AB ( STO:MANG ) should definitely note that the Chairman of...

Björn Borg AB (publ) ( STO:BORG ) missed earnings with its latest second-quarter results, disappointing...

What Sinch’s new Agent Tools launch means for the stock Sinch (OM:SINCH) has rolled out Agent Tools, a global suite that lets developers build and test communications apps inside familiar coding environments and AI assistants, including GitHub Copilot, Claude Code and ChatGPT Desktop. See our latest analysis for Sinch. For context, Sinch’s share price is SEK43.97, with a 1 month share price return of 12.57% and a year to date share price return of 43.32%. The 1 year total shareholder return...

Kjell Group stock closed at SEK13.9 on Tuesday after a muted few weeks, with the 30 day move roughly flat despite a solid rebound in the latest quarter. The headline is simple: losses are still there, yet the profit squeeze is easing. Q2 basic earnings per share came in at a loss of SEK0.13 on revenue of SEK574.25m, an improvement from the deeper loss in Q1. For short term traders that may not move the needle much. For longer term investors the real story is whether this gradual repair in...

Swedish Orphan Biovitrum (OM:SOBI) has moved into rare oncology with a new agreement with Innate Pharma that supports the TELLOMAK-3 Phase 3 trial of lacutamab in cutaneous T cell lymphoma. See our latest analysis for Swedish Orphan Biovitrum. The Innate Pharma agreement comes as Swedish Orphan Biovitrum trades at SEK457.8, with a year to date share price return of 38.56% and a 1 year total shareholder return of 62.92%. This suggests momentum has been building over the past year. If this move...

In recent weeks, global markets have experienced a mixed performance, with indices like the Russell 2000 and S&P MidCap 400 showing gains amid easing inflation concerns and fluctuating oil prices. As investors navigate these dynamic conditions, identifying promising small-cap stocks that may not yet be on everyone's radar can offer unique opportunities for growth. In this context, finding a good stock often involves looking beyond the headlines to discover companies with strong fundamentals...

The European market has experienced a mix of resilient economic data and geopolitical uncertainties, with the pan-European STOXX Europe 600 Index recently ending the week down slightly. Despite these challenges, small-cap stocks in Europe remain an area of interest for investors seeking opportunities, especially when insider actions suggest potential undervaluation. In such a dynamic environment, identifying stocks with strong fundamentals and strategic insider activity can be crucial for...

As European markets navigate through resilient economic data and geopolitical uncertainties, the pan-European STOXX Europe 600 Index recently experienced a slight decline amid fluctuating energy prices and geopolitical tensions. In this environment, growth companies with high insider ownership can offer unique insights into potential opportunities, as insider confidence often aligns with long-term strategic vision and resilience against market volatility.

In recent weeks, the European stock market has experienced mixed performance, with the pan-European STOXX Europe 600 Index slightly down as investors navigate resilient economic data against ongoing geopolitical uncertainties. Amid these conditions, identifying undervalued stocks can be a strategic approach for investors looking to capitalize on potential growth opportunities in sectors that may benefit from shifting market dynamics and regional resilience.

Last week, you might have seen that Transtema Group AB ( STO:TRANS ) released its quarterly result to the market. The...

Sharp pullbacks in the S&P 500 can feel uncomfortable, yet history shows that investors who steadily bought broad-market exposure during deep drawdowns and stayed invested saw powerful compounding at work. Volatility can turn into a long-term opportunity when you use low-cost index funds as your core. This article unpacks that idea and walks through 3 ETFs from our low-cost U.S. equity screener that are closely tied to this story. The ETFs in this article are just a starting sample, and the...

NCC AB previously announced that it had been commissioned by KOy Turun monitoimitilat to build a roughly 9,000-square-meter St Olof’s junior high school in Turku for about SEK 300,000,000, alongside a separate SEK 190,000,000 contract from Energinet to construct and expand high‑voltage substations in Denmark. These two Nordic contracts deepen NCC’s presence in both social infrastructure and energy transmission, broadening its order book across education and power-grid projects. We’ll now...

Modern Times Group MTG (OM:MTG B) has reorganised its core gaming operations under the new Playamp brand after consolidating studios such as Plarium, InnoGames and Ninja Kiwi, and has set up shared services in marketing, monetisation, AI and data. See our latest analysis for Modern Times Group MTG. The Playamp announcement comes after a period where Modern Times Group MTG’s share price has gathered momentum, with a 1-month share price return of 13.55% and a year-to-date share price return of...

What Embracer Group’s latest earnings mean for current and prospective shareholders Embracer Group (OM:EMBRAC B) has drawn fresh attention after reporting first quarter results on 13 August 2026, with higher sales and revenue and a move from a loss to a small profit. The company reported first quarter sales of SEK 3,943 million and revenue of SEK 4,006 million, compared with SEK 3,171 million and SEK 3,261 million a year earlier. Net income came in at SEK 39 million, compared with a net loss...

Sandvik (OM:SAND) has attracted attention after securing an order from Lucara Botswana to supply 15 underground drills and loaders for the Karowe diamond mine, including parts, services and a financing package. See our latest analysis for Sandvik. The Lucara Botswana order lands at a time when Sandvik’s share price has gained 6.24% over the past 30 days and 19.02% year to date, while the 1 year total shareholder return of 52.30% points to momentum that has been strong over a longer...

Whilst it may not be a huge deal, we thought it was good to see that the CAG Group AB (publ) ( STO:CAG ) President...

Genova Property Group stock closed Friday at SEK38.5, after a modestly positive run over the past week and quarter. Yet the real story in these Q2 numbers sits on the income statement. The headline is a profit profile under pressure. Quarterly revenue came in at SEK138 million with net income of SEK62 million, a step down from the previous two quarters and a reminder that last year’s very large one off gain will not do the heavy lifting forever. For long term holders the key question is...

It's been a good week for RaySearch Laboratories AB (publ) ( STO:RAY B ) shareholders, because the company has just...

Björn Borg stock has been drifting lower for months and closed at SEK62.6 on Friday, yet the latest quarter gives a different story about the underwear and sportswear business. The headline is earnings pressure. Q2 net income of SEK8.6 million on revenue of SEK203 million leaves much thinner profit than the punchy Q1 run rate, even as trailing 12 month earnings still look stronger and P/E screens below peers. For you as an investor, the question now is whether this margin squeeze is a blip in...

Boozt heads into the post earnings session with a stock that has cooled over the past week and month, yet sits meaningfully higher than three months ago. The headline is simple: Q2 revenue reached SEK 2,061m and earnings per share came in at SEK 1.19, backed by a clear beat on revenue growth and an EBIT margin near 6.5% that almost doubled on the quarter. For short term traders the recent share price swings matter, while for longer term holders the sharper profitability story is what now...

BTS Group walked into this earnings day with the stock up about 21% over three months and trading on a premium 26.3x trailing P/E, helped by a story of strong expected earnings growth. The market already priced in a lot of belief. The headline from the quarter is different. Q2 flipped from profit to a small net loss and earnings per share turned negative while revenue reached SEK 767.4m and management lifted the full year outlook. That gap between a high expectation stock and a messy quarter...